De Baere OLV
ActiveSummary
De Baere OLV has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93,136 and a net result of €2,247. Equity has been growing by about 27% per year since 2023. Its solvency ranks better than 51% of 22,773 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Overview
Official details
Source: KBO- Status
- Active since 23-11-2022 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.352.608.108 1760 Roosdaal, since 01-01-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 01-07-2025
Board and ownership
- DE BAERE Véronique Jozef JosephineDirector
- Verwee ConsultDirector · permanent representative ANRIJS Els
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.5%
- Gross margin
- €122,473
- ▲ 13.8%
- Turnover
- ≈ €390,000
- estimated
- Profit
- €2,247
- ▼ 95.2%
- Equity
- €93,136
- ▲ 2.5%
- Total assets
- €269,784
- ▼ 14.5%
- Employees on 31-12-2025
- 1
Score breakdownraises riskFounded in 2022Size: total assets €269,784lowers riskLiquidity: current ratio 2.68, cash €87,077Figures for financial year 2025 (filed on 30-06-2026)Show the evidence
Checked score
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 50% of them on solvency, 83% on liquidity, 34% on profitability and 46% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 3 accounts on average 50 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Higher gross margin than 81% of companies in retail tradesector median €34,182 · 22,708 companies €122,473 View
Recent changes
- · Gazette deed IncorporationStarting capital €25,000 · Appointments: DE BAERE Véronique Jozef Josephine (director) and VERWEE CONSULT (director) · Permanent representative: ANRIJS Els
Comparable companies
These companies have the same main activity as De Baere OLV: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €258,000 and €317,000, founded between 2022 and 2023.
| Company | Total assets | Gross margin |
|---|---|---|
| De Baere OLV Roosdaal | €269,784 | €122,473 |
| LOUIS WAUTERS Merksplas | €280,475 | €133,334 |
| C.E Pharma Sint-Jans-Molenbeek | €263,031 | €106,119 |
| APOTHEEK TEN EDE Wetteren | €281,689 | €113,856 |
| LIWOMA Kontich | €289,010 | €110,490 |
| PHARMACIE DE CAMPINE Liège | €317,399 | €109,432 |
| YASMIN LIBBRECHT Antwerpen | €258,250 | €93,300 |
Key facts about De Baere OLV
- What is the company number of De Baere OLV?
- The company number of De Baere OLV is 0793.872.546. The VAT number is the same number with BE in front: BE 0793.872.546.
- Where is De Baere OLV based?
- The registered office is at Koning Albertstraat 45, 1760 Roosdaal.Company details
- What does De Baere OLV do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of De Baere OLV?
- The legal form of De Baere OLV is Private limited company (BV).
- When was De Baere OLV founded?
- De Baere OLV was founded on 23-11-2022.
- Is De Baere OLV still active?
- Yes, De Baere OLV is an active enterprise in the KBO register.
- How many employees does De Baere OLV have?
- De Baere OLV had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of De Baere OLV?
- The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €122,473 and 32 comparable companies (NACE 477). It probably lies between €270,000 and €760,000.
- Is De Baere OLV profitable?
- In financial year 2025, De Baere OLV made a profit of €2,247.
- Where can I find the annual accounts of De Baere OLV?
- De Baere OLV filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of De Baere OLV due?
- De Baere OLV must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.